Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / CLASS A COMMON STOCK
-
Shares outstanding
-
117,557,908
-
Total 13F shares
-
38,929,050
-
Share change
-
+9,920,888
-
Total reported value
-
$2,426,163,019
-
Put/Call ratio
-
48%
-
Price per share
-
$62.32
-
Number of holders
-
102
-
Value change
-
+$612,574,707
-
Number of buys
-
68
-
Number of sells
-
30
Institutional Holders of 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) as of Q1 2020
As of 31 Mar 2020,
10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) was held by
102 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,929,050 shares.
The largest 10 holders included
Foresite Capital Management II, LLC, Foresite Capital Management I, LLC, MORGAN STANLEY, SB INVESTMENT ADVISERS (UK) LTD, FMR LLC, ALLIANCEBERNSTEIN L.P., JS Capital Management LLC, Invesco Ltd., VANGUARD GROUP INC, and LORD, ABBETT & CO. LLC.
This page lists
102
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.